Vycor Medical, Inc.
Other OTCTotal Valuation
Vycor Medical, Inc. carries a market capitalization of 2.30M, placing it among publicly traded companies globally. Its enterprise value stands at 3.81M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.30M |
| Enterprise Value | 3.81M |
Share Statistics
Vycor Medical, Inc. currently has 33.37M shares outstanding.
| Shares Outstanding | 33.37M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 1.59, and the price-to-book ratio stands at -0.09.
| PE Ratio | N/A |
| PS Ratio | 1.59 |
| PB Ratio | -0.09 |
| P/TBV Ratio | -0.71 |
| P/FCF Ratio | 27.63 |
| P/OCF Ratio | 26.61 |
Enterprise Valuation
On an enterprise value basis, Vycor Medical, Inc. trades at an EV/EBITDA multiple of 24.55 and an EV/FCF ratio of 17.48. The EV/Sales ratio of 2.02 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 41.19 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.02 |
| EV / EBITDA | 24.55 |
| EV / EBIT | 41.19 |
| EV / FCF | 17.48 |
Financial Position
Vycor Medical, Inc. maintains a current ratio of 0.13, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -23.19, indicating conservative leverage, while an interest coverage ratio of 1.50 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.13 |
| Quick Ratio | 0.07 |
| Debt / Equity | -23.19 |
| Debt / EBITDA | 6.32 |
| Interest Coverage | 1.50 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -1.53 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -1.38 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.72 |
Stock Price Statistics
Vycor Medical, Inc.'s stock has declined approximately -33.64747% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | -33.64747% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.11 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Vycor Medical, Inc. generated 1.89M in revenue and converted that into -13,755.00 in net income, yielding earnings per share of 0.00. EBITDA reached 155,215.00, while operating income came in at 92,514.00.
| Revenue | 1.89M |
| Gross Profit | 1.58M |
| Operating Income | 92,514.00 |
| Pretax Income | -11,581.00 |
| Net Income | -13,755.00 |
| EBITDA | 155,215.00 |
| EBIT | 92,514.00 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
Vycor Medical, Inc. holds 173,634.00 in cash and equivalents against 980,812.00 in total debt, resulting in a net debt position of 767,638.00. Total book value stands at -33.79M, with working capital of -4.30M providing operational flexibility.
| Cash & Cash Equivalents | 173,634.00 |
| Total Debt | 980,812.00 |
| Net Debt | 767,638.00 |
| Equity (Book Value) | -33.79M |
| Book Value Per Share | -1.01 |
| Working Capital | -4.30M |
Cash Flow
Vycor Medical, Inc. produced 112,860.00 in operating cash flow over the past twelve months. After subtracting -1,606.00 in capital expenditures, free cash flow totaled 111,254.00 - equivalent to 0.00 per share.
| Operating Cash Flow | 112,860.00 |
| Capital Expenditures | -1,606.00 |
| Free Cash Flow | 111,254.00 |
| FCF Per Share | 0.00 |
Margins
Vycor Medical, Inc. operates with a gross margin of 83.67, reflecting its pricing power and cost economics. The operating margin of 4.91 and net profit margin of -0.73 provide insight into operational efficiency.
| Gross Margin | 83.67 |
| Operating Margin | 4.91 |
| Pretax Margin | -0.61 |
| Profit Margin | -0.73 |
| EBITDA Margin | 8.23 |
Dividends & Yields
The company's payout ratio of 96.55 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 96.55 |
| Shareholder Yield | -0.07 |
| FCF Yield | 3.62 |
Stock Splits
Vycor Medical, Inc.'s most recent stock split took place on January 15, 2013 with a 150:1 split ratio.
| Last Split Date | 1/15/2013 |
| Split Ratio | 150:1 |
Scores
Vycor Medical, Inc. posts an Altman Z-Score of -58.51, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -58.51 |